BIO
Bio-Rad Laboratories, Inc.
Medical Devices · Healthcare · United States
384.40
close · 2026-10-29
value
42
cheaper than peers42
quality
62
stronger fundamentals62
ranked against
Medical Devices
value
quality
84 peerswide variation
caveat profit mostly non-recurring
Value inputs
| measure | company | vs peers |
| earnings yield, latest year | 7.8% | 95 |
| price to book | 1.43× | 73 |
| cash flow yield, latest year | 3.9% | 68 |
| cash flow yield, 2 years ago | 2.3% | 68 |
| cash flow yield, 3 years ago | 0.8% | 59 |
| cash flow yield, 1 year ago | 2.8% | 50 |
| price to sales | 3.59× | 39 |
| EV to EBITDA | 19.72× | 36 |
| earnings yield, 2 years ago | -6.1% | 32 |
| forward P/E | 39.44× | 25 |
| earnings yield, 1 year ago | -18.3% | 14 |
| earnings yield, 3 years ago | -34.2% | 5 |
12 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | 5.8% | 69 |
| return on equity | 2.5% | 68 |
| debt to equity | 20.1% | 66 |
| revenue growth | 1.1% | 29 |
4 of 4 measures available
Facts
| market cap | $10B |
| free cash flow | $229.8M |
| employees | 7,450 |
| first trade | 1980-02-27 |
| next earnings | 2026-11-04 |
| fundamentals updated | 2026-08-05 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | 27.85 | -65.36 | -21.82 | -121.79 |
| free cash flow | $374.6M | $266.2M | $218.2M | $80.1M |
| net income | $759.9M | -$1.84B | -$637.3M | -$3.63B |
| revenue | $2.58B | $2.57B | $2.67B | $2.80B |
| unusual items | $729.2M | -$2.65B | -$1.24B | -$5.20B |